MedPath

Mats Fredriksen

🇳🇴Norway
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

Phase 4
Completed
Conditions
Attention Deficit-Hyperactivity Disorder
Interventions
Drug: Placebo
First Posted Date
2013-04-15
Last Posted Date
2015-12-02
Lead Sponsor
Mats Fredriksen
Target Recruit Count
131
Registration Number
NCT01831622
Locations
🇳🇴

Department of Psychology, University of Oslo, Oslo, Norway

🇳🇴

Adult ADHD diagnostic clinic, Vestre Viken Hospital Trust, Tønsberg, Norway

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.